News & IIVS Activities

Respiratory Toxicology for Pharmaceutical Development

May 6, 2020

The Institute for In Vitro Sciences (IIVS) provides robust test systems and assays to detect the adverse effects of diverse materials, including pharmaceuticals targeting COVID-19. The IIVS Respiratory Toxicology Program offers testing services using cutting edge 3D pulmonary models - in addition to human 2D primary cells and lines - such as reconstructed human airways and precision-cut human lung...

FDA Releases New Guidance Recommending Alternatives to LLNA

April 22, 2020

FDA releases new guidance recommending the performance of alternative test methodologies in lieu of the murine-based Local Lymph Node Assay (LLNA) to assess skin sensitization potential for topically-applied drug products. This information can be found at 

Phototox and BCOP Russian Translations

February 25, 2020

IIVS, in collaboration with EPAA, is pleased to announce that our training videos for eye irritation and phototoxicity are now available with Russian subtitles. To view subtitled versions in different languages including Chinese, Portuguese and Spanish, please visit our YouTube channel.

2020 SOT Enhancement of Animal Welfare Award Announced

January 23, 2020

IIVS offers our congratulations to Kristie Sullivan, Vice President for Research Policy with the Physicians Committee for Responsible Medicine, who has been awarded the

PETA Science Group Donates $50,000 in Equipment to IIVS

October 11, 2019

Gaithersburg, Md. — Animals don't have to suffer for your cosmetics, cleaners, pesticides, or drugs. The PETA International Science Consortium Ltd. is donating $50,000 in equipment to the Institute for In Vitro Sciences (IIVS), a nonprofit laboratory in Gaithersburg that conducts and develops animal-free test methods. IIVS will use the VITROCELL® Cloud inhalation exposure system — instead of ...

US EPA Commits to Dramatically Reduce Animal Testing

September 13, 2019

The US EPA has committed to dramatically reducing animal testing with a commitment for total elimination by the year 2035. IIVS is proud to have played a part in the move to reduce animal testing, starting with the successful development, and acceptance, of the non-animal eye-irritation defined approach, which was developed by an industry and regulatory consortium led by IIVS' CEO Rodger D. ...

PETA Science Group and Tobacco Companies Donate to Save Animals

August 28, 2019

Donated Equipment Will Help to Replace Animals in Respiratory Toxicity Testing

Gaithersburg, MD — The PETA International Science Consortium Ltd., Imperial Brands PLC, Altria Client Services (ALCS), British American Tobacco PLC, and Philip Morris International Inc have joined together to donate equipment that can help to replace the use of animals in respiratory testing...

2020 Practical Methods for In Vitro Toxicology Workshop Announced

July 26, 2019

Save The Dates!

IIVS is pleased to announce the dates for our 2020 Practical Methods for In Vitro Toxicology Workshop which will be held at our facilities in Gaithersburg, Maryland, USA, and will begin on Monday afternoon, January 13, and finish on Thursday afternoon, January 16. This intensive workshop includes presentations from IIVS scientists and guest speakers. In ...